24 related articles for article (PubMed ID: 10613795)
1. E1A and the Ewing tumor translocation.
Kovar H
Nat Med; 1999 Dec; 5(12):1331. PubMed ID: 10581050
[No Abstract] [Full Text] [Related]
2. E1A and the Ewing tumor translocation.
Melot T; Delattre O
Nat Med; 1999 Dec; 5(12):1331. PubMed ID: 10581049
[No Abstract] [Full Text] [Related]
3. E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs.
Zhou Z; Jia SF; Hung MC; Kleinerman ES
Cancer Res; 2001 Apr; 61(8):3394-8. PubMed ID: 11309298
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics and cytogenetics of Ewing's sarcoma.
Kay BR
Med Sect Proc; 1995; ():103-8. PubMed ID: 8677240
[No Abstract] [Full Text] [Related]
5. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
6. Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.
Maire G; Brown CW; Bayani J; Pereira C; Gravel DH; Bell JC; Zielenska M; Squire JA
Cancer Genet Cytogenet; 2008 Mar; 181(2):81-92. PubMed ID: 18295659
[TBL] [Abstract][Full Text] [Related]
7. CD30+ anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with an unusual translocation t(11;22).
Schlaak M; Renner R; Treudler R; Harth W; Poenisch W; Kauer F; Grunewald S; Wittekind C; Simon JC
Br J Dermatol; 2008 Jul; 159(1):240-2. PubMed ID: 18489597
[No Abstract] [Full Text] [Related]
8. Current treatment for Ewing's sarcoma.
Thacker MM; Temple HT; Scully SP
Expert Rev Anticancer Ther; 2005 Apr; 5(2):319-31. PubMed ID: 15877528
[TBL] [Abstract][Full Text] [Related]
9. Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer.
Hung MC; Hortobagyi GN; Ueno NT
Adv Exp Med Biol; 2000; 465():171-80. PubMed ID: 10810625
[No Abstract] [Full Text] [Related]
10. Genomic integrity and the genetics of cancer.
Tlsty TD; White A; Livanos E; Sage M; Roelofs H; Briot A; Poulose B
Cold Spring Harb Symp Quant Biol; 1994; 59():265-75. PubMed ID: 7587078
[No Abstract] [Full Text] [Related]
11. Adenovirus E1A and Ewing tumors.
de Alava E; Sanchez-Prieto R; Ramon Y Cajal S
Nat Med; 2000 Jan; 6(1):4. PubMed ID: 10613795
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
